Technical Analysis for ENLV - Enlivex Therapeutics Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
NR7 | Range Contraction | -1.90% | |
Narrow Range Bar | Range Contraction | -1.90% | |
Wide Bands | Range Expansion | -1.90% | |
Narrow Range Bar | Range Contraction | -1.27% | |
Inside Day | Range Contraction | -1.27% | |
Wide Bands | Range Expansion | -1.27% | |
Wide Bands | Range Expansion | -4.32% |
Alert | Time |
---|---|
Down 3% | about 13 hours ago |
Fell Below Previous Day's Low | about 13 hours ago |
60 Minute Opening Range Breakdown | about 13 hours ago |
Down 2 % | about 13 hours ago |
Down 1% | about 13 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/01/2024
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.59 |
52 Week Low | 1.15 |
Average Volume | 210,695 |
200-Day Moving Average | 2.39 |
50-Day Moving Average | 2.89 |
20-Day Moving Average | 1.51 |
10-Day Moving Average | 1.58 |
Average True Range | 0.25 |
RSI (14) | 34.64 |
ADX | 30.66 |
+DI | 19.69 |
-DI | 30.25 |
Chandelier Exit (Long, 3 ATRs) | 3.47 |
Chandelier Exit (Short, 3 ATRs) | 1.89 |
Upper Bollinger Bands | 1.79 |
Lower Bollinger Band | 1.23 |
Percent B (%b) | 0.57 |
BandWidth | 37.38 |
MACD Line | -0.39 |
MACD Signal Line | -0.46 |
MACD Histogram | 0.0756 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.69 | ||||
Resistance 3 (R3) | 1.69 | 1.66 | 1.66 | ||
Resistance 2 (R2) | 1.66 | 1.62 | 1.65 | 1.65 | |
Resistance 1 (R1) | 1.60 | 1.60 | 1.59 | 1.60 | 1.65 |
Pivot Point | 1.57 | 1.57 | 1.56 | 1.56 | 1.57 |
Support 1 (S1) | 1.51 | 1.53 | 1.50 | 1.51 | 1.45 |
Support 2 (S2) | 1.48 | 1.51 | 1.47 | 1.45 | |
Support 3 (S3) | 1.42 | 1.48 | 1.44 | ||
Support 4 (S4) | 1.42 |